# CrossAmerica Partners LP: financial statements, quarterly

CAPL · NYSE · CIK 1538849 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/capl.md) · [Financials](/companies/capl/financials.md) · [Filings](/companies/capl/filings.md) · [Insiders](/companies/capl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/capl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,210](/filings/0000950170-24-122489.md) | [1,015 d](/filings/0001193125-26-071870.md) | [942](/filings/0000950170-25-066051.md) | [1,133](/filings/0000950170-25-104308.md) | [1,079](/filings/0001193125-25-267170.md) | [944 d](/filings/0001193125-26-071870.md) | [862](/filings/0001193125-26-209202.md) | [962](/filings/0001193125-26-335346.md) | [972](/filings/0001193125-25-267170.md) | [866 d](/filings/0001193125-26-071870.md) | [842](/filings/0001193125-26-209202.md) | [1,179](/filings/0001193125-26-335346.md) |
| Cost of revenue | $m | [1,110](/filings/0000950170-24-122489.md) | [913 d](/filings/0001193125-26-071870.md) | [860](/filings/0000950170-25-066051.md) | [1,029](/filings/0000950170-25-104308.md) | [968](/filings/0001193125-25-267170.md) | [843 d](/filings/0001193125-26-071870.md) | [773](/filings/0001193125-26-209202.md) | [861](/filings/0001193125-26-335346.md) | [867](/filings/0001193125-25-267170.md) | [759 d](/filings/0001193125-26-071870.md) | [744](/filings/0001193125-26-209202.md) | [1,066](/filings/0001193125-26-335346.md) |
| Gross profit | $m | [100](/filings/0000950170-24-122489.md) | [102 d](/filings/0001193125-26-071870.md) | [81.3](/filings/0000950170-25-066051.md) | [105](/filings/0000950170-25-104308.md) | [111](/filings/0001193125-25-267170.md) | [101 d](/filings/0001193125-26-071870.md) | [89.8](/filings/0001193125-26-209202.md) | [101](/filings/0001193125-26-335346.md) | [105](/filings/0001193125-25-267170.md) | [107 d](/filings/0001193125-26-071870.md) | [97.6](/filings/0001193125-26-209202.md) | [113](/filings/0001193125-26-335346.md) |
| Selling, general and administrative | $m | [6.9](/filings/0000950170-24-122489.md) | [6.9 d](/filings/0001193125-26-071870.md) | [6.8](/filings/0000950170-25-066051.md) | [7.9](/filings/0000950170-25-104308.md) | [7.3](/filings/0001193125-25-267170.md) | [6.7 d](/filings/0001193125-26-071870.md) | [7.7](/filings/0001193125-26-209202.md) | [6.6](/filings/0001193125-26-335346.md) | [6.5](/filings/0001193125-25-267170.md) | [7.2 d](/filings/0001193125-26-071870.md) | [6.5](/filings/0001193125-26-209202.md) | [6.8](/filings/0001193125-26-335346.md) |
| Operating income | $m | [24.1](/filings/0000950170-24-122489.md) | [27.0 d](/filings/0001193125-26-071870.md) | [(13.0)](/filings/0000950170-25-066051.md) | [28.2](/filings/0000950170-25-104308.md) | [27.1](/filings/0001193125-25-267170.md) | [28.3 d](/filings/0001193125-26-071870.md) | [2.0](/filings/0001193125-26-209202.md) | [41.5](/filings/0001193125-26-335346.md) | [28.1](/filings/0001193125-25-267170.md) | [26.1 d](/filings/0001193125-26-071870.md) | [23.8](/filings/0001193125-26-209202.md) | [35.3](/filings/0001193125-26-335346.md) |
| Interest expense | $m | [10.6](/filings/0000950170-24-122489.md) | [10.5 d](/filings/0001193125-26-071870.md) | [10.5](/filings/0000950170-25-066051.md) | [14.2](/filings/0000950170-25-104308.md) | [14.2](/filings/0001193125-25-267170.md) | [13.4 d](/filings/0001193125-26-071870.md) | [12.8](/filings/0001193125-26-209202.md) | [12.6](/filings/0001193125-26-335346.md) | [11.8](/filings/0001193125-25-267170.md) | [10.9 d](/filings/0001193125-26-071870.md) | [10.8](/filings/0001193125-26-209202.md) | [11.3](/filings/0001193125-26-335346.md) |
| Income tax | $m | [1.5](/filings/0000950170-24-122489.md) | [(0.1) d](/filings/0001193125-26-071870.md) | [(5.8)](/filings/0000950170-25-066051.md) | [1.7](/filings/0000950170-25-104308.md) | [2.4](/filings/0001193125-25-267170.md) | [(1.8) d](/filings/0001193125-26-071870.md) | [(3.6)](/filings/0001193125-26-209202.md) | [3.9](/filings/0001193125-26-335346.md) | [2.9](/filings/0001193125-25-267170.md) | [5.1 d](/filings/0001193125-26-071870.md) | [2.5](/filings/0001193125-26-209202.md) | [3.3](/filings/0001193125-26-335346.md) |
| Net income | $m | [12.3](/filings/0000950170-24-122489.md) | [16.7 d](/filings/0001193125-26-071870.md) | [(17.5)](/filings/0000950170-25-104308.md) | [12.4](/filings/0000950170-25-104308.md) | [10.7](/filings/0001193125-25-267170.md) | [16.9 d](/filings/0001193125-26-071870.md) | [(7.1)](/filings/0001193125-26-335346.md) | [25.2](/filings/0001193125-26-335346.md) | [13.6](/filings/0001193125-25-267170.md) | [10.2 d](/filings/0001193125-26-071870.md) | [10.7](/filings/0001193125-26-335346.md) | [20.8](/filings/0001193125-26-335346.md) |
| Diluted EPS | $ per share | [0.31](/filings/0000950170-24-122489.md) | not reported | [(0.48)](/filings/0000950170-25-066051.md) | [0.31](/filings/0000950170-25-104308.md) | [0.27](/filings/0001193125-25-267170.md) | not reported | [(0.20)](/filings/0001193125-26-209202.md) | [0.64](/filings/0001193125-26-335346.md) | [0.34](/filings/0001193125-25-267170.md) | not reported | [0.26](/filings/0001193125-26-209202.md) | [0.52](/filings/0001193125-26-335346.md) |
| Basic EPS | $ per share | [0.31](/filings/0000950170-24-122489.md) | not reported | [(0.48)](/filings/0000950170-25-066051.md) | [0.31](/filings/0000950170-25-104308.md) | [0.27](/filings/0001193125-25-267170.md) | not reported | [(0.20)](/filings/0001193125-26-209202.md) | [0.64](/filings/0001193125-26-335346.md) | [0.34](/filings/0001193125-25-267170.md) | not reported | [0.26](/filings/0001193125-26-209202.md) | [0.53](/filings/0001193125-26-335346.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [5.8](/filings/0000950170-23-060430.md) | [5.0](/filings/0000950170-25-028082.md) | [6.3](/filings/0000950170-24-056002.md) | [5.5](/filings/0000950170-24-093061.md) | [7.8](/filings/0000950170-24-122489.md) | [3.4](/filings/0001193125-26-071870.md) | [6.7](/filings/0000950170-25-066051.md) | [9.7](/filings/0000950170-25-104308.md) | [5.8](/filings/0001193125-25-267170.md) | [3.1](/filings/0001193125-26-335346.md) | [7.3](/filings/0001193125-26-209202.md) | [4.9](/filings/0001193125-26-335346.md) |
| Current assets | $m | [123](/filings/0000950170-23-060430.md) | [109](/filings/0000950170-25-028082.md) | [123](/filings/0000950170-24-056002.md) | [126](/filings/0000950170-24-093061.md) | [126](/filings/0000950170-24-122489.md) | [119](/filings/0001193125-26-071870.md) | [151](/filings/0000950170-25-066051.md) | [125](/filings/0000950170-25-104308.md) | [117](/filings/0001193125-25-267170.md) | [111](/filings/0001193125-26-335346.md) | [125](/filings/0001193125-26-209202.md) | [123](/filings/0001193125-26-335346.md) |
| Total assets | $m | [1,217](/filings/0000950170-23-060430.md) | [1,182](/filings/0000950170-25-028082.md) | [1,179](/filings/0000950170-24-056002.md) | [1,165](/filings/0000950170-24-093061.md) | [1,130](/filings/0000950170-24-122489.md) | [1,115](/filings/0001193125-26-071870.md) | [1,087](/filings/0000950170-25-066051.md) | [1,028](/filings/0000950170-25-104308.md) | [999](/filings/0001193125-25-267170.md) | [965](/filings/0001193125-26-335346.md) | [1,003](/filings/0001193125-26-209202.md) | [982](/filings/0001193125-26-335346.md) |
| Current liabilities | $m | [177](/filings/0000950170-23-060430.md) | [161](/filings/0000950170-25-028082.md) | [160](/filings/0000950170-24-056002.md) | [165](/filings/0000950170-24-093061.md) | [173](/filings/0000950170-24-122489.md) | [163](/filings/0001193125-26-071870.md) | [164](/filings/0000950170-25-066051.md) | [162](/filings/0000950170-25-104308.md) | [164](/filings/0001193125-25-267170.md) | [150](/filings/0001193125-26-335346.md) | [168](/filings/0001193125-26-209202.md) | [162](/filings/0001193125-26-335346.md) |
| Total liabilities | $m | [1,168](/filings/0000950170-23-060430.md) | [1,151](/filings/0000950170-25-028082.md) | [1,181](/filings/0000950170-24-056002.md) | [1,173](/filings/0000950170-24-093061.md) | [1,161](/filings/0000950170-24-122489.md) | [1,140](/filings/0001193125-26-071870.md) | [1,143](/filings/0000950170-25-066051.md) | [1,083](/filings/0000950170-25-104308.md) | [1,061](/filings/0001193125-25-267170.md) | [1,037](/filings/0001193125-26-335346.md) | [1,081](/filings/0001193125-26-209202.md) | [1,058](/filings/0001193125-26-335346.md) |
| Long-term debt | $m | [771](/filings/0000950170-23-060430.md) | [764](/filings/0000950170-24-020383.md) | not reported | not reported | not reported | [772](/filings/0000950170-25-028082.md) | not reported | not reported | not reported | [693](/filings/0001193125-26-071870.md) | [732](/filings/0001193125-26-209202.md) | [721](/filings/0001193125-26-335346.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: not reported

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [31.7 d](/filings/0000950170-24-122489.md) | [38.1 d](/filings/0001193125-26-071870.md) | [5.8](/filings/0000950170-25-066051.md) | [28.9 d](/filings/0000950170-25-104308.md) | [41.9 d](/filings/0001193125-25-267170.md) | [11.1 d](/filings/0001193125-26-071870.md) | [15.0](/filings/0001193125-26-209202.md) | [22.7 d](/filings/0001193125-26-335346.md) | [24.4 d](/filings/0001193125-25-267170.md) | [29.4 d](/filings/0001193125-26-071870.md) | [27.9](/filings/0001193125-26-209202.md) | [33.2 d](/filings/0001193125-26-335346.md) |
| Capital expenditure | $m | [10.4 d](/filings/0000950170-24-122489.md) | [12.9 d](/filings/0001193125-26-071870.md) | [6.1](/filings/0000950170-25-066051.md) | [5.3 d](/filings/0000950170-25-104308.md) | [7.7 d](/filings/0001193125-25-267170.md) | [7.2 d](/filings/0001193125-26-071870.md) | [10.1](/filings/0001193125-26-209202.md) | [11.8 d](/filings/0001193125-26-335346.md) | [6.7 d](/filings/0001193125-25-267170.md) | [7.1 d](/filings/0001193125-26-071870.md) | [3.4](/filings/0001193125-26-209202.md) | [7.4 d](/filings/0001193125-26-335346.md) |
| Dividends paid | $m | [19.9 d](/filings/0000950170-24-122489.md) | [19.9 d](/filings/0001193125-26-071870.md) | [19.9](/filings/0000950170-25-066051.md) | [20.0 d](/filings/0000950170-25-104308.md) | [20.0 d](/filings/0001193125-25-267170.md) | [20.0 d](/filings/0001193125-26-071870.md) | [20.0](/filings/0001193125-26-209202.md) | [20.0 d](/filings/0001193125-26-335346.md) | [20.0 d](/filings/0001193125-25-267170.md) | [20.0 d](/filings/0001193125-26-071870.md) | [20.0](/filings/0001193125-26-209202.md) | [20.0 d](/filings/0001193125-26-335346.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.0](/filings/0000950170-23-060430.md) | [37.9](/filings/0000950170-24-056002.md) | [38.2](/filings/0000950170-24-093061.md) | [38.1](/filings/0000950170-24-122489.md) | [38.0](/filings/0000950170-25-066051.md) | [38.2](/filings/0000950170-25-104308.md) | [38.2](/filings/0001193125-25-267170.md) | [38.1](/filings/0001193125-26-209202.md) | [39.5](/filings/0001193125-26-335346.md) | [38.3](/filings/0001193125-25-267170.md) | [38.3](/filings/0001193125-26-209202.md) | [38.3](/filings/0001193125-26-335346.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 38,173,255 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001193125-26-335346.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.